跳转至内容
Merck
CN

SML0269

尼替西农

≥95% (HPLC), 4-Hydroxyphenylpyruvate oxidase inhibitor, powder

别名:

2-(2-硝基-4-三氟甲基苯甲酰基)-1,3-环己二酮, 2-[2-硝基-4-(三氟甲基)苯甲酰基] 环己烷-1,3-二酮, NTBC, SC 0735, 尼替松

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C14H10F3NO5
化学文摘社编号:
分子量:
329.23
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

尼替西农, ≥95% (HPLC)

SMILES string

[O-][N+](=O)c1cc(ccc1C(=O)C2C(=O)CCCC2=O)C(F)(F)F

InChI key

OUBCNLGXQFSTLU-UHFFFAOYSA-N

InChI

1S/C14H10F3NO5/c15-14(16,17)7-4-5-8(9(6-7)18(22)23)13(21)12-10(19)2-1-3-11(12)20/h4-6,12H,1-3H2

assay

≥95% (HPLC)

form

powder

color

white to brown

solubility

DMSO: ≥5 mg/mL

storage temp.

−20°C

Quality Level

Gene Information

human ... HPD(3242)

正在寻找类似产品? 访问 产品对比指南

Application

尼替西农已经被用于:
  • 诱导肝损伤
  • 治疗 肩突硬蜱 细胞,抑制羟苯丙酮酸双加氧酶
  • 在补充水中的活性以阻止有毒代谢产物在人肝细胞移植小鼠中的蓄积,
  • 以研究其对细菌性脓疱素产生的影响。

Biochem/physiol Actions

尼替西农是4-羟苯基丙酮酸氧化酶(双加氧酶)的竞争性和可逆抑制剂。
尼替西农是一种竞品抑制剂,可逆地抑制4-羟苯基丙酮酸氧化酶(双加氧酶)。尼替西农用于治疗1型遗传性酪氨酸血症,可阻止酪氨酸降解为有害物质。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Corinne de Laet et al.
Orphanet journal of rare diseases, 8, 8-8 (2013-01-15)
The management of tyrosinaemia type 1 (HT1, fumarylacetoacetase deficiency) has been revolutionised by the introduction of nitisinone but dietary treatment remains essential and the management is not easy. In this review detailed recommendations for the management are made based on
Methods to inhibit bacterial pyomelanin production and determine the corresponding increase in sensitivity to oxidative stress
Ketelboeter LM and Bardy SL
Journal of Visualized Experiments, (102), e53105-e53105 (2015)
Johannes Sander et al.
Clinica chimica acta; international journal of clinical chemistry, 412(1-2), 134-138 (2010-10-05)
Quantification of nitisinone, 2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione (NTBC) has been repeatedly described. Nevertheless monitoring of NTBC has not yet become part of routine therapy surveillance in tyrosinaemia type I (OMIM 276700). We developed a blood spot test to facilitate collection and transport of
Immunization with AgTRIO, a protein in Anopheles saliva, contributes to protection against Plasmodium infection in mice
Dragovic SM, et al.
Cell host & microbe, 23(4), 523-535 (2018)
Saikat Santra et al.
Expert opinion on pharmacotherapy, 9(7), 1229-1236 (2008-04-22)
Hereditary tyrosinaemia type 1 is a rare inherited metabolic condition, which leads to a fatal multisystemic disease in childhood. Since 1992, nitisinone - a compound developed from work on triketone herbicides - has become an effective pharmacological treatment by inhibiting

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持